Literature DB >> 4020300

Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues.

A H Merrill, D W Nixon, R D Williams.   

Abstract

Serine palmitoyltransferase [EC 2.3.1.50] catalyzes the first unique reaction of sphingolipid biosynthesis. To determine whether or not different rat tissues are capable of initiating this pathway, its activity was determined for microsomes from rat liver, lung, brain, kidney, intestine, spleen, muscle, heart, pancreas, testes, ovary, and stomach. Serine palmitoyltransferase was found in every tissue, and, when compared to the microsomal glycerol 3-phosphate acyltransferase, the activities correlated directly with their sphingomyelin levels as a percentage of total phospholipids. This suggests that the activities were comparable to expected cellular needs for long-chain bases, if the initial enzymes of glycerolipid and sphingolipid biosynthesis influence the phospholipid composition of cells by determining the relative partitioning of fatty acyl-CoA's toward these two lipid classes. Serine palmitoyltransferase activities were also determined using different fatty acyl-CoA's and were consistently greatest with CoA thioesters of saturated fatty acids with 16 +/- 1 carbon atoms. This suggests that the predominance of 18-carbon long-chain bases in vivo is due to the higher activity of this enzyme with palmitoyl-CoA. Together, these findings indicate a role for serine palmitoyltransferase in regulating both the type and amount of long-chain bases found in tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020300

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  25 in total

1.  An improved method to determine serine palmitoyltransferase activity.

Authors:  Markus F Rütti; Stéphane Richard; Anke Penno; Arnold von Eckardstein; Thorsten Hornemann
Journal:  J Lipid Res       Date:  2009-01-29       Impact factor: 5.922

2.  Transmembrane topology of mammalian ORMDL proteins in the endoplasmic reticulum as revealed by the substituted cysteine accessibility method (SCAM™).

Authors:  Deanna Davis; John Suemitsu; Binks Wattenberg
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-01-10       Impact factor: 3.036

3.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Authors:  Ts Jeong; S L Schissel; I Tabas; H J Pownall; A R Tall; X Jiang
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 4.  Orm/ORMDL proteins: Gate guardians and master regulators.

Authors:  Deanna Davis; Muthukumar Kannan; Binks Wattenberg
Journal:  Adv Biol Regul       Date:  2018-08-31

Review 5.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

6.  Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids.

Authors:  R Buede; C Rinker-Schaffer; W J Pinto; R L Lester; R C Dickson
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

7.  Sphingolipid Long-Chain Base Synthesis in Plants (Characterization of Serine Palmitoyltransferase Activity in Squash Fruit Microsomes).

Authors:  D. V. Lynch; S. R. Fairfield
Journal:  Plant Physiol       Date:  1993-12       Impact factor: 8.340

8.  Differences in the long chain (sphingoid) base composition of sphingomyelin from rats bearing Morris hepatoma 7777.

Authors:  A H Merrill; E Wang; P W Wertz
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

9.  Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.

Authors:  Sarah Brice Russo; Rotem Tidhar; Anthony H Futerman; L Ashley Cowart
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

10.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.